Evolent Health (EVH) EV to CFO (2015 - 2026)

Evolent Health has reported EV to CFO for 12 years, with the latest figure at 50.61 in Q2 2026.

• On a quarterly basis, EV to CFO fell 34.07% year-over-year to 50.61 in Q2 2026; TTM through Jun 2026 was 8.68, a 125.25% increase from a year earlier, with the FY2025 full-year figure at 6.84, down 88.67% from the prior year.
• EV to CFO was 50.61 for Q2 2026 at Evolent Health, up from 89.14 in the prior quarter.
• The five-year high for EV to CFO was 4929.22 in Q2 2023, with the low at 991.63 in Q3 2022.
• Average EV to CFO over 5 years is 268.06, with a median of 44.09 recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: EV to CFO plunged 1872.26% in 2022, then surged 2557.19% in 2023.
• Over 5 years, EV to CFO stood at 81.33 in 2022, then tumbled by 50.63% to 40.16 in 2023, then sank by 207.58% to 43.2 in 2024, then jumped by 112.61% to 5.45 in 2025, then slumped by 1029.05% to 50.61 in 2026.
• The last three EV to CFO figures came in at 50.61 (Q2 2026), 89.14 (Q1 2026), and 5.45 (Q4 2025), per Business Quant data.